Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study
- Resource Type
- Article
- Source
- In
Leukemia Research April 2024 139 - Subject
- Language
- ISSN
- 0145-2126